Trials / Active Not Recruiting

Active Not RecruitingNCT02690441

Physical Exercise Augmented CBT for GAD

Physical Exercise Augmented Cognitive Behaviour Therapy for Older Adults With Generalised Anxiety Disorder

Status: Active Not Recruiting
Phase: N/A
Study type: Interventional
Enrollment: 53 (actual)

Sponsor: Solli Distriktspsykiatriske Senter · Academic / Other
Sex: All
Age: 60 Years – 75 Years
Healthy volunteers: Not accepted

Summary

Generalised anxiety disorder (GAD) is a severe and debilitating anxiety disorder that is highly prevalent among older adults. Anxiety and GAD is a well-documented risk factor for the development of other severe conditions such as depression and dementia, and effective treatments are called for. However, recommended treatment for GAD has consistently been found to yield blunted response rates for older adults compared to younger patients. The purpose of this study is to evaluate the effects of exercise-augmented cognitive behaviour therapy for older adults with GAD. Exercise augmented CBT is expected to yield better results than standard CBT in terms of greater reduction of symptoms and increased rates of remission. The investigators will also investigate the effects of treatment on biological, physiological and neuropsychological measures.

Conditions

Generalized Anxiety Disorder

Interventions

Type	Name	Description
BEHAVIORAL	Cognitive Behavioural Therapy	Cognitive behavioural therapy conducted individually. 10 weekly sessions, first session lasts 90 minutes, the remaining sessions last 45 minutes.
BEHAVIORAL	Physical Exercise	Manualised exercise. 15 weekly sessions with instructor, and two weekly unsupervised sessions performed individually.
BEHAVIORAL	Placebo control	One follow-up telephone call à 15 minutes each week for 15 weeks. Aims to control for therapist contact in physical exercise condition and total duration of treatment.

Timeline

Start date: 2016-03-01
Primary completion: 2023-10-01
Completion: 2025-12-01
First posted: 2016-02-24
Last updated: 2025-09-22

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT02690441. Inclusion in this directory is not an endorsement.